Encurebio
This company develops next-generation cardiovascular therapeutics by integrating AI, quantum-grade modeling, and human cardiac organoids. They focus on discovering new targets and designing organ-targeted therapies for complex heart and vascular diseases. The goal is to deliver effective and affordable treatments that address existing gaps in cardiovascular care.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops next-generation cardiovascular therapeutics by integrating AI, quantum-grade modeling, and human cardiac organoids. They focus on discovering new targets and designing organ-targeted therapies for complex heart and vascular diseases. The goal is to deliver effective and affordable treatments that address existing gaps in cardiovascular care.